Therapeutic potential of cytokine and chemokine antagonists in cancer therapy

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Li YanMarian T Nakada

Abstract

A new paradigm is becoming widely accepted, that chronic inflammation, driven in part by chemokines and cytokines at the site of a tumour, may facilitate tumour progression instead of promoting anti-tumour immunity. Tumours and activated stromal cells secrete pro-inflammatory chemokines and cytokines that act either directly or indirectly through stimulation of the vascular endothelium to recruit leukocytes to the tumour. After activation, these tumour-associated leukocytes release angiogenic factors, mitogens, proteolytic enzymes, and chemotactic factors, recruiting more inflammatory cells and stimulating angiogenesis to sustain tumour growth and facilitate tumour metastasis. Breaking this cycle by inhibiting targets such as cytokines, chemokines and other inflammatory mediators, either alone, or more realistically, in combination with other therapies, such as anti-angiogenic or cytotoxic agents, may provide highly efficacious therapeutic regimens for the treatment of malignancies. This article reviews anti-cytokine and anti-chemokine therapies being pursued in cancer, and discusses in more detail anti-tumour necrosis factor-alpha (TNF) approaches.

References

Dec 11, 1992·Science·A E KochR M Strieter
Nov 1, 1995·American Journal of Surgery·S E von BibersteinD L Kreutzer
May 1, 1995·Occupational and Environmental Medicine·R PartanenK Hemminki
Jul 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·B E TurkJ O Liu
Feb 15, 1996·The Journal of Surgical Research·F F IsikC E Alpers
Feb 14, 1998·Journal of Clinical Pathology·V CostesJ F Rossi
Nov 13, 1998·The Journal of Biological Chemistry·D J FalconeL Fernandes
Jul 27, 1999·International Journal of Cancer. Journal International Du Cancer·V GoedeH G Augustin
Nov 24, 1999·The New England Journal of Medicine·S SinghalB Barlogie
Dec 21, 2000·European Journal of Clinical Investigation·M BossolaF Rossi Fanelli
Feb 24, 2001·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·G MantovaniA Dessì
Aug 24, 2001·International Journal of Cancer. Journal International Du Cancer·C LissM W Lingen
Oct 13, 2001·Cancer·R Kurzrock
Nov 17, 2001·JAMA : the Journal of the American Medical Association·L A LiottaE F Petricoin
Mar 20, 2002·Cytokine & Growth Factor Reviews·Fran Balkwill
Jul 13, 2002·Expert Review of Anticancer Therapy·Apostolia-Maria Tsimberidou, Francis J Giles
Oct 16, 2002·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Parisa AriapartInger Lundkvist
Oct 25, 2002·International Journal of Cancer. Journal International Du Cancer·Masahiro OhtaKazuaki Chayama
Nov 5, 2002·Nature Reviews. Cancer·Michael J Tisdale
Dec 6, 2002·The International Journal of Neuropsychopharmacology·Marieke Wichers, Michael Maes
Jun 14, 2003·Current Opinion in Clinical Nutrition and Metabolic Care·Josep M ArgilésFrancisco J López-Soriano
Jun 20, 2003·Nature Reviews. Drug Discovery·Erik De Clercq
Sep 26, 2003·American Journal of Hematology·David A JacobsohnGeorgia B Vogelsang
Nov 5, 2003·Proceedings of the National Academy of Sciences of the United States of America·Joshua B RubinRosalind A Segal
Jan 7, 2004·Nature Reviews. Cancer·Glenn Dranoff
Jan 30, 2004·Cytokine & Growth Factor Reviews·Steeve Kwan TatYannick Fortun
Apr 8, 2004·Blood·Daniel CourielRichard Champlin
Apr 14, 2004·Current Pharmaceutical Design·David A Jacobsohn, Georgia B Vogelsang
Apr 21, 2004·Journal of the American Academy of Dermatology·Adam C EsserJohn A Doyle
Jun 23, 2004·Biochemical and Biophysical Research Communications·M TakenagaR Igarashi
Aug 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gayle G VadayStanley Zucker

❮ Previous
Next ❯

Citations

May 14, 2010·Human Reproduction Update·K E MayC M Becker
Oct 5, 2012·Journal of Cardiothoracic Surgery·Michail KlimatsidasKyriakos Rammos
Oct 7, 2009·Biological Chemistry·Peter Arne GerberBernhard Homey
Feb 7, 2012·Biochemical Pharmacology·Anton KuratnikCharles Giardina
Mar 5, 2011·Analytical Biochemistry·Palaniswami RathanaswamiIan N Foltz
Nov 26, 2008·Drug Discovery Today·Edward Tobinick
Jan 29, 2009·Biochemical Pharmacology·Isabelle BuckMarc Diederich
Jul 17, 2007·Cancer Letters·Dayanidhi RamanAnn Richmond
Feb 20, 2007·Molecular Aspects of Medicine·Sonia MinuzzoAlberto Amadori
Dec 5, 2006·Biochemical and Biophysical Research Communications·Yu-Chih LiuLu-Ping Chow
Oct 11, 2008·Fundamental & Clinical Pharmacology·G Y Perret, M Crépin
Jun 1, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Beatriz ArtetaFernando Vidal-Vanaclocha
Jun 5, 2014·Journal of Cellular and Molecular Medicine·Oksana ShynlovaStephen Lye
Jun 6, 2014·Journal of Immunology Research·Glauben LandskronMarcela A Hermoso
Apr 16, 2008·Expert Opinion on Therapeutic Targets·Josée Golay, Martino Introna
Mar 5, 2010·Clinical Pharmacology and Therapeutics·F Balkwill, A Mantovani
Nov 11, 2016·Viral Immunology·Nimrah AkramAhmed Bilal Waqar
Oct 26, 2018·International Journal of Cancer. Journal International Du Cancer·Eyun SongTae Yong Kim
Nov 10, 2007·Dalton Transactions : an International Journal of Inorganic Chemistry·Graeme McRobbieStephen J Archibald
Oct 16, 2007·International Journal of Cancer. Journal International Du Cancer·Donatella AldinucciAlfonso Colombatti
Jan 16, 2007·Chemical Communications : Chem Comm·Abid KhanStephen J Archibald
Jun 21, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Lone SkovJan G J van de Winkel
Aug 25, 2015·Oncotarget·Mohamed Ali MosratiPeter Söderkvist
Apr 19, 2017·The Journal of International Medical Research·Izabela Maciejewska-PaszekTomasz Irzyniec
Oct 14, 2008·Experimental Biology and Medicine·Eduardo FerreroAngel Luis García-Villalon
Jun 28, 2018·Frontiers in Cell and Developmental Biology·Elizabeth A ComenMaria Kleppe
Mar 26, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Aparajita KhatriPamela J Russell

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.